Consiglio di Stato, sentenza n. 1654 del 9 marzo 2020
Continue readingTag Archives: whistleblowing
Sanzione di 30.000 euro per mancata adozione di strumenti di crittografia e diffusione di dati delle segnalazioni da whistleblowing
I pubblici dipendenti devono sempre guardare all’interesse pubblico, che trascende l’interesse dell’ente datore di lavoro
Non si può accedere fraudolentemente al sistema informatico, e poi invocare la tutela del whistleblowing
Non è whistleblower chi agisce a tutela dei propri diritti di lavoratore
Le dichiarazioni “secretate” durante il procedimento disciplinare, poi devono essere accessibili nel giudizio civile
La tutela del nome del whistleblower? Opera solo in ambito disciplinare, non in ambito penale
L’obbligo di fedeltà del lavoratore non può trasformarsi in dovere di omertà
Corte di Cassazione, sez. L, sentenza n. 4125 del 16 febbraio 2017
Il Collegio ritiene di dovere dare continuità all’orientamento già espresso da questa Corte che, chiamata a valutare condotte analoghe a quella addebitata al ricorrente, ha escluso che la denuncia di fatti di potenziale rilievo penale Continue reading
A whistleblower will receive $31,83 million, share of $256 million paid from Millenium Health
Millennium Health, formerly Millennium Laboratories, has agreed to pay $256 million to resolve alleged violations of the False Claims Act for billing Medicare, Medicaid and other federal health care programs for medically unnecessary urine drug and genetic testing and for providing free items to physicians who agreed to refer expensive laboratory testing business to Millennium, the Justice Department announced today.
The whistleblowers will receive $30.35 million from the False Claims Act recovery for the urine drug testing claims and $1.48 million from the False Claims Act recovery for the genetic testing claims.
Millennium, headquartered in San Diego, is one of the largest urine drug testing laboratories in the United States and conducts business nationwide.
As part of today’s announced settlements, Millennium has agreed to pay $227 million to resolve False Claims Act allegations, detailed in a complaint filed by the United States, that Millennium systematically billed federal health care programs for excessive and unnecessary urine drug testing from Jan. 1, 2008, through May 20, 2015. The United States alleged that Millennium caused physicians to order excessive numbers of urine drug tests, in part through the promotion of “custom profiles,” which, instead of being tailored to individual patients, were in effect standing orders that caused physicians to order large number of tests without an individualized assessment of each patient’s needs. This practice violated federal healthcare program rules limiting payment to services that are reasonable and medically necessary for the treatment and diagnosis of an individual patient’s illness or injury. The United States also alleged that Millennium’s provision of free point of care urine drug test cups to physicians—expressly conditioned on the physicians’ agreement to return the urine specimens to Millennium for hundreds of dollars’ worth of additional testing—violated the Stark Law and the Anti-Kickback Statute. The Stark Law and the Anti-Kickback Statute generally prohibit laboratories from giving physicians anything of value in exchange for referrals of tests.
Millennium has also agreed to pay $10 million to resolve False Claims Act allegations that it submitted false claims to federal health care programs from Jan. 1, 2012, through May 20, 2015, for genetic testing that was performed routinely and without an individualized assessment of need.
The False Claims Act allegations resolved were originally brought in lawsuits filed by whistleblowers under the qui tamprovisions of the False Claims Act, which allow private parties to bring suit on behalf of the government and to share in any recovery. Under the act, the United States can elect to intervene in an action filed by a whistleblower, as it did, in part, with respect to several of the qui tamactions regarding urine drug testing allegations.
Un whistleblower riceverà circa 18,1 milioni di dollari, parte della sanzione che un ospedale del Sud Carolina pagherà agli Stati Uniti.
Il Dipartimento di Giustizia USA ha annunciato che ha concluso un contenzioso del valore di 237 milioni di dollari con un ospedale del Sud Carolina, per servizi a pazienti indirizzati da medici che avevano una relazione finanziaria con l’ospedale, cioè venivano compensati con partecipazioni o utili in rapporto ai pazienti che indirizzavano.
Il Governo riceverà 72,4 milioni di dollari.
La Stark Law prescrive che i medici siano pagati secondo il valore medio di mercato, e non in rapporto al volume dei pazienti indirizzati all’ospedale.
Invece, l’ospedale pagava gli specialisti esterni secondo il numero di pazienti da indirizzare, in tal modo superando la retribuzione media, e pagava loro i profitti con parte di quanto riceveva dal programma sanitario del Governo.
Il valore della truffa è stato stimato dalla Corte d’Appello in 237 milioni di dollari, con sentenza del 2 luglio 2015.
L’illegittimità è stata segnalata da un medico che ha rifiutato di sottoscrivere il contratto, e che ora riceverà circa 18 milioni di dollari.
In allegato la sentenza del 2 luglio.
United States Resolves $237 Million False Claims _appello02072015
A whistleblower will receive approximately $18.1 million, share of the payment ($72,4) that United States will receive from South Carolina Hospital.
The Department of Justice announced that it has resolved a $237 million judgment against Tuomey Healthcare System for illegally billing the Medicare program for services referred by physicians with whom the hospital had improper financial relationships. Under the terms of the settlement agreement, the United States will receive $72.4 million and Tuomey, based in Sumter, South Carolina, will be sold to Palmetto Health, a multi-hospital healthcare system based in Columbia, South Carolina.
“Secret sweetheart deals between hospitals and physicians, like the ones in this case, undermine patient confidence and drive up healthcare costs for everybody, including the Medicare program and its beneficiaries,” said Principal Deputy Assistant Attorney General Benjamin C. Mizer, head of the Justice Department’s Civil Division. “This case demonstrates the United States’ commitment to ensuring that doctors who refer Medicare beneficiaries to hospitals for procedures, tests and other health services do so only because they believe the service is in the patient’s best interest, and not because the physician stands to gain financially from the referral. The Department of Justice is determined to prevent the kind of abuses uncovered in this case, and we are willing to take such cases to trial to protect the integrity of the Medicare program.”
The judgment against Tuomey related to violations of the Stark Law, a statute that prohibits hospitals from billing Medicare for certain services (including inpatient and outpatient hospital care) that have been referred by physicians with whom the hospital has an improper financial relationship. The Stark Law includes exceptions for many common hospital-physician arrangements, but generally requires that any payments that a hospital makes to a referring physician be at fair market value for the physician’s actual services, and not take into account the volume or value of the physician’s referrals to the hospital.
The government argued in this case that Tuomey, fearing that it could lose lucrative outpatient procedure referrals to a new freestanding surgery center, entered into contracts with 19 specialist physicians that required the physicians to refer their outpatient procedures to Tuomey and, in exchange, paid them compensation that far exceeded fair market value and included part of the money Tuomey received from Medicare for the referred procedures. The government argued that Tuomey ignored and suppressed warnings from one of its attorneys that the physician contracts were “risky” and raised “red flags.”
On May 8, 2013, after a month-long trial, a South Carolina jury determined that the contracts violated the Stark Law. The jury also concluded that Tuomey had filed more than 21,000 false claims with Medicare. On Oct. 2, 2013, the trial court entered a judgment under the False Claims Act in favor of the United States for more than $237 million. The United States Court of Appeals for the Fourth Circuit affirmed the judgment on July 2, 2015.
“This case reinforces the need for hospitals to abide by the requirements of the Stark Law,” said U.S. Attorney Thomas G. Walker of the Eastern District of North Carolina.
The case arose from a lawsuit filed on Oct. 4, 2005, by Dr. Michael K. Drakeford, an orthopedic surgeon who was offered, but refused to sign, one of the illegal contracts. The lawsuit was filed under the qui tam,or whistleblower, provisions of the False Claims Act, which permit private individuals to sue on behalf of the government for false claims and to share in any recovery. The act allows the government to intervene and take over the action, as it did in this case. Dr. Drakeford will receive approximately $18.1 million under the settlement.
“The type of abusive compensation arrangements at issue in this case is precisely what the physician self-referral law was designed to prevent,” said Inspector General Dan Levinson of of the Department of Health and Human Services-Office of the Inspector General (HHS-OIG). “Patients need and deserve to know that the hospital services they receive are the product of sound medical judgment, rather than motivated by the physician’s financial interests. The extensive litigation and settlement in this case should send a signal to the hospital industry that these tainted financial relationships simply will not be tolerated.”
As part of the settlement announced today, Tuomey will be required to retain an independent review organization to monitor any arrangements it makes with physicians or other sources of referrals for the duration of the five-year Corporate Integrity Agreement.
This case illustrates the government’s emphasis on combating health care fraud and marks another achievement for the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, which was announced in May 2009 by the Attorney General and the Secretary of Health and Human Services. The partnership between the two departments has focused efforts to reduce and prevent Medicare and Medicaid financial fraud through enhanced cooperation. One of the most powerful tools in this effort is the False Claims Act. Since January 2009, the Justice Department has recovered a total of more than $25.3 billion through False Claims Act cases, with more than $16.1 billion of that amount recovered in cases involving fraud against federal health care programs. Tips and complaints from all sources about potential fraud, waste, abuse, and mismanagement, including the conduct described in the opinions of the trial and appellate courts in this case, can be reported to the Department of Health and Human Services, at 800-HHS-TIPS (800-447-8477).
The judgment and resolution of the case were the result of a coordinated effort by the Civil Division’s Commercial Litigation branch, the U.S. Attorney’s Office of the Eastern District of North Carolina and HHS-OIG.
The case is captioned United States ex rel. Drakeford v. Tuomey Healthcare System, Inc., Case No. 3:05-cv-02858 (MBS) (D.S.C.).
United States Resolves $237 Million False Claims Act Judgment against South Carolina Hospital that Made Illegal Payments to Referring Physicians _ OPA _ Department of Justice